16-Jan-2026
Neogen Reports Progress in Strategic Transformation as Core Revenue Rises and Outlook Improves
Market Chameleon (Thu, 8-Jan 6:14 AM ET)
Neogen’s Core Revenue Growth and Margin Improvement Highlight Strategic Progress Amid Transition
Market Chameleon (Thu, 8-Jan 2:52 AM ET)
Neogen Announces Second-Quarter 2026 Results
Business Wire (Thu, 8-Jan 7:00 AM ET)
Neogen Announces Two Senior Leadership Appointments
Business Wire (Mon, 5-Jan 8:45 AM ET)
Neogen Announces Second-Quarter Earnings Release Date
Business Wire (Thu, 18-Dec 9:00 AM ET)
Neogen To Participate in Upcoming Investor Conferences
Business Wire (Wed, 17-Dec 4:15 PM ET)
PRNewswire (Tue, 16-Dec 11:26 AM ET)
Kuehn Law Encourages Investors of Neogen Corporation to Contact Law Firm
Globe Newswire (Mon, 10-Nov 10:32 AM ET)
Neogen Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer
Business Wire (Thu, 30-Oct 8:45 AM ET)
Market Chameleon (Thu, 9-Oct 3:30 AM ET)
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Neogen trades on the NASDAQ stock market under the symbol NEOG.
As of January 16, 2026, NEOG stock price declined to $9.25 with 1,823,396 million shares trading.
NEOG has a beta of 0.93, meaning it tends to be less sensitive to market movements. NEOG has a correlation of 0.05 to the broad based SPY ETF.
NEOG has a market cap of $2.01 billion. This is considered a Mid Cap stock.
Last quarter Neogen reported $225 million in Revenue and $.10 earnings per share. This beat revenue expectation by $16 million and exceeded earnings estimates by $.04.
In the last 3 years, NEOG traded as high as $24.10 and as low as $3.87.
The top ETF exchange traded funds that NEOG belongs to (by Net Assets): IJR, IWM, VTI, VB, VBR.
NEOG has underperformed the market in the last year with a return of -20.3%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NEOG shares. However, NEOG has outperformed the market in the last 3 month and 2 week periods, returning +56.0% and +32.1%, while SPY returned +5.0% and +1.2%, respectively. This indicates NEOG has been having a stronger performance recently.
NEOG support price is $9.11 and resistance is $9.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NEOG shares will trade within this expected range on the day.